CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 157 filers reported holding CLOVIS ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.74 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $576,000 | -54.4% | 483,593 | -31.1% | 0.00% | – |
| Q2 2022 | $1,263,000 | -0.6% | 701,699 | +11.6% | 0.00% | – |
| Q1 2022 | $1,270,000 | +28.5% | 628,756 | +72.5% | 0.00% | – |
| Q4 2021 | $988,000 | -78.6% | 364,543 | -64.8% | 0.00% | -100.0% |
| Q3 2021 | $4,619,000 | -49.7% | 1,035,596 | -34.6% | 0.00% | 0.0% |
| Q2 2021 | $9,184,000 | +27.0% | 1,583,663 | +53.7% | 0.00% | 0.0% |
| Q1 2021 | $7,234,000 | +37.7% | 1,030,479 | -5.9% | 0.00% | 0.0% |
| Q4 2020 | $5,254,000 | -60.5% | 1,094,781 | -52.0% | 0.00% | -66.7% |
| Q3 2020 | $13,300,000 | +275.7% | 2,281,257 | +334.9% | 0.00% | +200.0% |
| Q2 2020 | $3,540,000 | -3.9% | 524,506 | -9.5% | 0.00% | 0.0% |
| Q1 2020 | $3,685,000 | -40.6% | 579,345 | -2.6% | 0.00% | 0.0% |
| Q4 2019 | $6,203,000 | -24.9% | 594,980 | -71.7% | 0.00% | -50.0% |
| Q3 2019 | $8,262,000 | +22.1% | 2,102,190 | +361.8% | 0.00% | 0.0% |
| Q2 2019 | $6,768,000 | -34.0% | 455,192 | +10.1% | 0.00% | -33.3% |
| Q1 2019 | $10,257,000 | -15.6% | 413,251 | -39.0% | 0.00% | -25.0% |
| Q4 2018 | $12,158,000 | +12.9% | 676,970 | +84.7% | 0.00% | +33.3% |
| Q3 2018 | $10,765,000 | -42.0% | 366,522 | -10.1% | 0.00% | -40.0% |
| Q2 2018 | $18,546,000 | -13.4% | 407,876 | +0.6% | 0.01% | -16.7% |
| Q1 2018 | $21,415,000 | +42.2% | 405,590 | +83.1% | 0.01% | +50.0% |
| Q4 2017 | $15,061,000 | -8.1% | 221,473 | +11.3% | 0.00% | -20.0% |
| Q3 2017 | $16,390,000 | +34.2% | 198,903 | +52.5% | 0.01% | +25.0% |
| Q2 2017 | $12,211,000 | -39.9% | 130,409 | -59.1% | 0.00% | +33.3% |
| Q1 2017 | $20,314,000 | +23.9% | 319,072 | -13.6% | 0.00% | 0.0% |
| Q4 2016 | $16,400,000 | -42.3% | 369,196 | -53.2% | 0.00% | -70.0% |
| Q3 2016 | $28,424,000 | +40.6% | 788,462 | -46.5% | 0.01% | +42.9% |
| Q2 2016 | $20,213,000 | +429.3% | 1,473,342 | +640.8% | 0.01% | +600.0% |
| Q1 2016 | $3,819,000 | -42.8% | 198,893 | +4.3% | 0.00% | -50.0% |
| Q4 2015 | $6,675,000 | -77.7% | 190,703 | -41.3% | 0.00% | -81.8% |
| Q3 2015 | $29,894,000 | +8.4% | 325,075 | +3.6% | 0.01% | +10.0% |
| Q2 2015 | $27,577,000 | +15.5% | 313,807 | -2.5% | 0.01% | +11.1% |
| Q1 2015 | $23,880,000 | +8.2% | 321,706 | -18.4% | 0.01% | +12.5% |
| Q4 2014 | $22,077,000 | +278.1% | 394,247 | +206.3% | 0.01% | +300.0% |
| Q3 2014 | $5,839,000 | +308.0% | 128,708 | +272.6% | 0.00% | +100.0% |
| Q2 2014 | $1,431,000 | +16.2% | 34,547 | +94.4% | 0.00% | 0.0% |
| Q1 2014 | $1,231,000 | +561.8% | 17,774 | +475.6% | 0.00% | – |
| Q4 2013 | $186,000 | -95.0% | 3,088 | -94.9% | 0.00% | -100.0% |
| Q3 2013 | $3,692,000 | -15.2% | 60,745 | -6.6% | 0.00% | 0.0% |
| Q2 2013 | $4,353,000 | – | 65,003 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 3,997,826 | $10,834,000 | 0.69% |
| Ikarian Capital, LLC | 1,112,669 | $3,016,000 | 0.45% |
| Versant Venture Management, LLC | 101,855 | $276,000 | 0.15% |
| Virtus ETF Advisers LLC | 60,836 | $165,000 | 0.06% |
| EMFO, LLC | 21,500 | $58,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| QVT Financial LP | 505,000 | $1,369,000 | 0.05% |
| PINNACLE ASSOCIATES LTD | 706,336 | $1,914,000 | 0.03% |
| XTX Topco Ltd | 20,920 | $57,000 | 0.03% |
| State of Wyoming | 25,419 | $69,000 | 0.03% |